<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2707">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04386083</url>
  </required_header>
  <id_info>
    <org_study_id>RGAO-2020-0348</org_study_id>
    <nct_id>NCT04386083</nct_id>
  </id_info>
  <brief_title>Neurologic Manifestations of COVID-19</brief_title>
  <acronym>CORONA</acronym>
  <official_title>COVID-19 Outcomes: A Retrospective Study of Neurological Manifestations and Associated Symptoms (The Philippine CORONA Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of the Philippines</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asian Hospital and Medical Center, Muntinlupa City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baguio General Hospital and Medical Center, Baguio City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cagayan Valley Medical Center, Tuguegarao City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Capitol Medical Center, Quezon City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardinal Santos Medical Center, San Juan City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chong Hua Hospital, Cebu City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>De La Salle University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>East Avenue Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jose B. Lingad Memorial Regional Hospital, San Fernando, Pampanga, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jose R. Reyes Memorial Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lung Center of the Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Manila Doctors Hospital, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Manila Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Makati Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New Era General Hospital, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Quirino Memorial Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospital ng Makati, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Pablo O. Torre Memorial Hospital, Bacolod City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Philippine Heart Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Research Institute for Tropical Medicine, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Juan De Dios Educational Foundation Inc. - Hospital, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Lazaro Hospital, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southern Isabela Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Luke's Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Lukes Medical Center, Bonifacio Global City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southern Philippines Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Medical City, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of the East Ramon Magsaysay Memorial Medical Center, Inc, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Santo Tomas Hospital, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Veterans Memorial Medical Center, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jose N. Rodriguez Memorial Hospital, Caloocan City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zamboanga City Medical Center, Zamboanga City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Western Visayas Medical Center, Iloilo City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northern Mindanao Medical Center, Cagayan de Oro City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vicente Sotto Memorial Medical Center, Cebu City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Perpetual Succor Hospital, Cebu City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of the Philippines</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the neurological profile and predictors of outcomes in patients
      with COVID-19 disease in the Philippines. It will also evaluate if there is significant
      difference between COVID-19 patients with neurological manifestations compared to those
      COVID-19 patients without neurological manifestations in terms of various prespecified
      clinical outcomes. Furthermore, the likelihood of these outcomes in COVID-19 patients with
      neurological manifestations compared to those without neurological manifestation will be
      determined in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This quantitative, retrospective, cohort study will determine the following: 1) demographic,
      clinical and neurological profile of patients with COVID-19 disease in the Philippines; 2)
      the frequency of neurological symptoms and new-onset neurological disorders/complications in
      patients with COVID-19 disease; 3) the neurological manifestations that are significant
      predictors of mortality, respiratory failure, duration of ventilator dependence, intensive
      care unit (ICU) admission, length of ICU stay, and length of hospital stay; 4) if there is
      significant difference between COVID-19 patients with neurological manifestations compared to
      those COVID-19 patients without neurological manifestations in terms of mortality,
      respiratory failure, duration of ventilator dependence, ICU admission, length of ICU stay and
      length of hospital stay; and 5) the likelihood of mortality, respiratory failure and ICU
      admission in COVID-19 patients with neurological manifestations compared to those without
      neurological manifestations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality (binary outcome)</measure>
    <time_frame>from admission until occurrence of mortality, assessed up to 6 months</time_frame>
    <description>Defined as patients with confirmed COVID-19 who died</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory failure (binary outcome)</measure>
    <time_frame>from admission until occurrence of respiratory failure, assessed up to 6 months</time_frame>
    <description>Defined as the patient with confirmed COVID-19 who experienced clinical symptoms and signs of respiratory insufficiency. Clinically, this condition may manifest as tachypnea, abnormal blood gases (hypoxemia or hypercapnia), signs of increased work of breathing, and requires oxygen supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ventilator dependence (continuous outcome)</measure>
    <time_frame>day of intubation to day of extubation, assessed up to 6 months</time_frame>
    <description>Defined as the number of days from initiation of assisted ventilation to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit (ICU) admission (binary outcome)</measure>
    <time_frame>admission to ICU admission, assessed up to 6 months</time_frame>
    <description>Defined as the patients with confirmed COVID-19 who are admitted to an ICU or ICU-comparable setting</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Length of ICU stay (continuous outcome)</measure>
    <time_frame>ICU admission to ICU discharge, assessed up to 6 months</time_frame>
    <description>Defined as the number of days admitted in the ICU or ICU-comparable setting</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of hospital stay (continuous outcome)</measure>
    <time_frame>admission to hospital discharge, assessed up to 6 months</time_frame>
    <description>Defined as the number of days from admission to discharge</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1342</enrollment>
  <condition>Coronavirus Disease 2019</condition>
  <arm_group>
    <arm_group_label>COVID-19 patients with neurologic manifestations</arm_group_label>
    <description>Patients with confirmed COVID-19 disease who presented with neurological symptoms or new-onset neurological disorders/complications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 patients without neurologic manifestations</arm_group_label>
    <description>Patients with confirmed COVID-19 disease who did not present with neurological symptoms or new-onset neurological disorders/complications</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with confirmed COVID-19 disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cases confirmed by testing approved patient samples (i.e. nasal swabs, sputum,
             bronchoalveolar lavage fluid) employing the real-time reverse transcriptase polymerase
             chain reaction (RT-PCR) from COVID-19 testing centers accredited by the DOH;

          -  adult patients at least 19 years of age;

          -  male or female;

          -  cases with clinical symptoms and signs attributable to COVID-19 disease (i.e.
             respiratory as well as non-respiratory clinical signs and symptoms), with or without
             the availability of ancillary tests (i.e. complete blood count, chest x-ray); cases
             with disposition (i.e. discharged or died) at the end of the study period.

        Exclusion Criteria:

          -  Pediatric patients â‰¤18 years

          -  Cases with conditions of diseases caused by other organisms (i.e. bacteria, other
             viruses, fungi, etc.) or caused by other pathologies unrelated to COVID-19 disease
             (i.e., trauma).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Adrian I Espiritu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the Philippines</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrian I Espiritu, MD</last_name>
    <phone>+639258520341</phone>
    <email>aiespiritu@up.edu.ph</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roland Dominic G Jamora, MD</last_name>
    <phone>+639985438062</phone>
    <email>rgjamora@up.edu.ph</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Philippine General Hospital - University of the Philippines Manila</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian I Espiritu, MD</last_name>
      <phone>+639258520341</phone>
      <email>aiespiritu@up.edu.ph</email>
    </contact>
    <contact_backup>
      <last_name>Roland Dominic G Jamora, MD</last_name>
      <phone>+639985438062</phone>
      <email>rgjamora@up.edu.ph</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>July 25, 2020</last_update_submitted>
  <last_update_submitted_qc>July 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of the Philippines</investigator_affiliation>
    <investigator_full_name>Adrian Espiritu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>neurological manifestations</keyword>
  <keyword>outcomes</keyword>
  <keyword>cohort study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Neurologic Manifestations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Researchers may be able to request data through an official letter addressed to the Steering Committee of the &quot;The Philippine CORONA Study&quot; e-mailed to coronastudyph@gmail.com.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be stored for 5 years after completion of the study.</ipd_time_frame>
    <ipd_access_criteria>Data may be requested through an official letter addressed to the Steering Committee of the &quot;The Philippine CORONA Study&quot; e-mailed to coronastudyph@gmail.com.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

